selected scholarly activity
-
conferences
- The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma. Journal of Clinical Oncology. 2022
- The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. TPS12144-TPS12144. 2022
- Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease. International Journal of Radiation Oncology Biology Physics. e479-e479. 2021
- 52: Impact of Stereotactic Body Radiotherapy (SBRT) in Oligoprogressive Metastatic Disease. Radiotherapy and Oncology. S25-S25. 2021
- Treatment patterns and survival outcomes of older patients with advanced pancreatic cancer (APC): A Canadian real-world evidence study.. Journal of Clinical Oncology. 385-385. 2021
- LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC). Annals of Oncology. S1195-S1195. 2020
- Clinical outcomes of pancreas cancer patients with peritoneal spread: Results from the chord consortium.. Journal of Clinical Oncology. 2020
- The impact of primary pancreatic tumor location on clinical outcomes in advanced disease: Results from the chord consortium.. Journal of Clinical Oncology. 2020
- Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO). Cancer Research. CT122-CT122. 2019
- Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO). Clinical Trials. ct122-ct122. 2019
- Prognostic factors associated with short-term survival (STS) in advanced pancreatic cancer (APC): A Canadian multicenter analysis from the CHORD Consortium.. Journal of Clinical Oncology. e15717-e15717. 2019
- Prognostic factors associated with long term survival in chemotherapy-treated advanced pancreatic cancer: A Canadian multicenter analysis.. Journal of Clinical Oncology. 416-416. 2019
- Chemotherapy choice in advanced pancreatic cancer: What patient and disease factors influence prescription patterns?. Journal of Clinical Oncology. 327-327. 2018
- Comparative effectiveness and safety of the implementation of universal public funding of FOLFIRINOX (FFX) and gemcitabine (G) + nab-paclitaxel (GnP) in advanced pancreatic cancer (APC): A population-based study.. Journal of Clinical Oncology. 375-375. 2018
- Outcomes of FOLFIRINOX (FFX) and gemcitabine+nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study.. Journal of Clinical Oncology. 394-394. 2017
- Reasons for delay in time to initiation of adjuvant chemotherapy (TTAC) for colon cancer (CC): Analysis from six academic centers in Ontario, Canada.. Journal of Clinical Oncology. 6541-6541. 2016
- Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer: A multi-institution study.. Journal of Clinical Oncology. e14504-e14504. 2014
- Cochrane systematic review and meta-analysis of adjuvant chemotherapy for stage II colon cancer. Journal of Clinical Oncology. 2013
- Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients.. Journal of Clinical Oncology. 2013
- Rapid assessment of frailty prior to treatment of elderly colorectal cancer patients.. Journal of Clinical Oncology. e20522-e20522. 2013
- PATIENT FACTORS INVOLVED IN REFERRAL FOR LYNCH SYNDROME. Annals of Oncology. 91-91. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC). Journal of Clinical Oncology. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC).. Journal of Clinical Oncology. 2012
- CARB 31-Synthesis of S-ribosylhomocysteine analogs modified at carbon-3. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 559-559. 2007
- 2132. International Journal of Radiation Oncology Biology Physics. S284-S284. 2006
- 3-Deoxy analogues of S-ribosylhomocysteine: Targeting LuxS enzyme. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2006
- CABG and PCI rates differ between genders even with similar coronary anatomy: A computer based patient simulation explores the gender gap. Journal of the American College of Cardiology. 266A-266A. 2006
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 624S-624S. 2005
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results.. Journal of Clinical Oncology. 1095S-1095S. 2005
-
journal articles
- Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.. Immunotherapy. ahead-of-print:1-7. 2024
- Impact of Wait Time From Preoperative CT to Pancreatectomy on Overall Survival for Patients With Pancreatic Carcinoma.. Canadian Association of Radiologists Journal. 8465371241275150. 2024
- LBA37 Final results: Randomized assessment of cisplatin dosing interval for ototoxicity (RADIO) trial comparing chemoradiation (CRT) with cisplatin q3weekly to weekly for locally advanced squamous cell carcinoma of the head and neck (LASCCHN). Annals of Oncology. 35:s1228. 2024
- Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.. Journal of Clinical Oncology. 42:2918-2927. 2024
- Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.. Cancers. 16:2878. 2024
- Impact of pre-operative abdominal MRI on survival for patients with resected pancreatic carcinoma: a population-based study. The Lancet Regional Health - Americas. 35:100809-100809. 2024
- Atezolizumab + bevacizumab versus lenvatinib as first-line systemic therapy for treatment of hepatocellular carcinoma in a real-world population: Outcomes from the HCC CHORD database.. Journal of Clinical Oncology. 42:4111-4111. 2024
- Predictors of short-term death and long-term survival in advanced hepatocellular carcinoma (HCC) treated with contemporary tyrosine kinase inhibitors (TKI) or immunotherapy: A multicenter analysis from the HCC-CHORD consortium.. Journal of Clinical Oncology. 42:4098-4098. 2024
- Acute Toxicity Results from the Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity (RADIO) Trial Comparing Chemoradiation (CRT) with Cisplatin Q3weekly to Weekly for Locally Advanced Squamous Cell Carcinoma of the Head and neck (LASCCHN). International Journal of Radiation Oncology Biology Physics. 118:e9-e9. 2024
- Treatment modalities to manage hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and meta-analysis. Annals of Palliative Medicine. 12:1165-1174. 2023
- Treatment Modalities to Manage Hepatocellular Carcinoma Patients with Portal Vein Thrombus: A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology Biology Physics. 117:e319-e319. 2023
- Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?. Oral Oncology. 143:106444-106444. 2023
- The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma – A systematic review. Cancer Treatment Reviews. 118:102584-102584. 2023
- Real-world multicentre analysis of patients with hepatocellular carcinoma (HCC) treated with atezolizumab and bevacizumab (A+B): Efficacy, esophagogastroduodenoscopy (EGD) uptake and bleeding complications.. Journal of Clinical Oncology. 41:4105-4105. 2023
- Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada. Cancer Treatment Reviews. 115:102526-102526. 2023
- Dosing, efficacy and safety of lenvatinb in the real‐world treatment of hepatocellular carcinoma: Results from a Canadian database. Liver Cancer International. 3:119-127. 2022
- The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma. Nature Communications. 13:5020. 2022
- Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA network open. 5:e2222721-e2222721. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease. Acta Oncologica. 61:705-713. 2022
- Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.. Acta Oncologica. 61:705-713. 2022
- Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib. Hepatology. 74:1705-1707. 2021
- Non-surgical management of advanced hepatocellular carcinoma: A systematic review by Cancer Care Ontario. Canadian Liver Journal. 4:257-274. 2021
- Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Reports. 3:100260-100260. 2021
- Impact of lenvatinib (LEN) dose-intensity and starting dose on survival among patients with advanced hepatocellular carcinoma (HCC): Results from a Canadian multicenter database (HCC CHORD).. Journal of Clinical Oncology. 39:e16142-e16142. 2021
- The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective. Canadian Journal of Gastroenterology and Hepatology. 2021:1-8. 2021
- Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review. Journal of the National Cancer Institute. 113:123-136. 2021
- Efficacy and safety of lenvatinib in the real-world treatment of hepatocellular carcinoma: Results from a Canadian multicenter database (HCC CHORD).. Journal of Clinical Oncology. 39:275-275. 2021
- MRI vs. CT for the Detection of Liver Metastases in Patients With Pancreatic Carcinoma: A Comparative Diagnostic Test Accuracy Systematic Review and Meta‐Analysis. Journal of Magnetic Resonance Imaging. 53:38-48. 2021
- The addition of radiofrequency ablation for patients receiving sorafenib: new evidence for a new standard?. ANNALS OF TRANSLATIONAL MEDICINE. 9:3-3. 2021
- Evolution of Cancer Care in Response to the COVID-19 Pandemic. Oncologist. 25:e1426-e1427. 2020
- In Reply. Oncologist. 25:e1252-e1253. 2020
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 25:e936-e945. 2020
- In Reply. Oncologist. 25:E1252-E1253. 2020
- Clinical outcomes of pancreas cancer patients with peritoneal spread: Results from the chord consortium.. Journal of Clinical Oncology. 38:e19268-e19268. 2020
- Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 38:e16656-e16656. 2020
- The impact of primary pancreatic tumor location on clinical outcomes in advanced disease: Results from the chord consortium.. Journal of Clinical Oncology. 38:e19267-e19267. 2020
- Hypovascular pancreas head adenocarcinoma: CT texture analysis for assessment of resection margin status and high-risk features. European Radiology. 30:2853-2860. 2020
- Nonsurgical Management of Advanced Hepatocellular Carcinoma: A Clinical Practice Guideline. Current Oncology. 27:106-114. 2020
- Effect of neoadjuvant immunotherapy and targeted therapies on surgical resection in patients with solid tumors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 38:511-511. 2020
- Prognostic factors associated with short-term survival (STS) in advanced pancreatic cancer (APC): A multicenter analysis from the CHORD consortium.. Journal of Clinical Oncology. 38:650-650. 2020
- Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis. Cancer Medicine. 9:160-169. 2020
- A real-world multicenter analysis of first (1L) and second line (2L) treatment of advanced pancreatic adenocarcinoma (APC).. Journal of Clinical Oncology. 36:e16210-e16210. 2018
- A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases. Cureus. 10:e2320. 2018
- A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 36:476-476. 2018
- Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study. International Journal of Surgery Protocols. 8:1-6. 2018
- Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review. Clinical Oncology. 29:459-465. 2017
- Systemic Therapy in the Curative Treatment of Head-and-Neck Squamous Cell Cancer: Cancer Care Ontario Clinical Practice Guideline. Current Oncology. 24:157-162. 2017
- Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Journal of Gastrointestinal Oncology. 8:32-38. 2017
- Effects of stepwise dry/wet-aging and freezing on meat quality of beef loins. Meat Science. 123:57-63. 2017
- Systemic therapy in the curative treatment of head and neck squamous cell cancer: A systematic review. Journal of Otolaryngology - Head and Neck Surgery. 46:29. 2017
- Adjuvant Systemic Chemotherapy for Stages II and III Colon Cancer after Complete Resection: A Clinical Practice Guideline. Current Oncology. 23:418-424. 2016
- 233: Sinonasal Undifferentiated Carcinoma with Brain Metastasis: A Case Report and Review of Literature. Radiotherapy and Oncology. 120:S85-S85. 2016
- Effects of stepwise dry/wet aging on physical, chemical and quality attributes of beef loins. Meat Science. 112:136-137. 2016
- Systemic treatment patterns in small bowel and appendiceal adenocarcinomas (SBA and AA): A population-based study.. Journal of Clinical Oncology. 34:242-242. 2016
- Cochrane systematic review and meta-analysis of adjuvant therapy for stage II colon cancer.. Journal of Clinical Oncology. 33:3513-3513. 2015
- Locoregional Therapy of Locally Advanced Breast Cancer: A Clinical Practice Guideline. Current Oncology. 22:54-66. 2015
- Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon Cancer: a Multi-Institution Study. Annals of Oncology. 25:iv198-iv198. 2014
- Cochrane systematic review and meta-analysis of adjuvant chemotherapy for stage II colon cancer.. Journal of Clinical Oncology. 31:3548-3548. 2013
- P-0215 Patient Factors Involved in Referral for Lynch Syndrome. Annals of Oncology. 23:iv91-iv91. 2012
- Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer (CRC).. Journal of Clinical Oncology. 30:e14001-e14001. 2012
- Is Colon Cancer Survival Influenced by Tumor Location?. Journal of Clinical Oncology. 30:1732-1733. 2012
- Chemotherapy for colorectal cancer. The Lancet Oncology. 13:e3-e4. 2012
- Coronary artery bypass graft surgery and primary percutaneous coronary intervention choices in patients with similar coronary anatomy: A computer-based simulation examines the sex gap. Canadian Journal of Cardiology. 25:649-653. 2009
- Sweet Taste in Man: A Review. Journal of Food Science. 73:R81-R90. 2008
- S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results. Journal of Clinical Oncology. 23:LBA7012-LBA7012. 2005
- A breast-feeding assessment score to evaluate the risk for cessation of breast-feeding by 7 to 10 days of age. Journal of Pediatrics. 141:659-664. 2002
- Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole–intolerant orthotopic liver transplant patients: A preliminary study. Liver Transplantation. 7:750-751. 2001
- A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome. Intensive Care Medicine. 27:1169-1178. 2001
- Effects of oral erythrosine (2′,4′,5′,7′-tetraiodofluorescein) on thyroid function in normal men. Toxicology and Applied Pharmacology. 91:299-304. 1987
-
preprints